Skip to content

Apo-M: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Apo-M

BE 0837.707.638
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€197,010
2024 · €194,931+€2,079
Equity
€290,262
2024 · €98,252+€192,010
Cash
€280,841
2024 · €291,749-€10,909
Balance sheet total
€852,674
2024 · €880,949-€28,274

Largest movements

2024 to 2025
Assets
  • Current investments -€106,327

    down €106,327 (-100.0%), from €106,327 to €0

  • Receivables within one year +€99,087

    up €99,087 (+61.8%), from €160,277 to €259,364

    of which Trade receivables: +€79,181

  • Intangible fixed assets -€40,000

    down €40,000 (-100.0%), from €40,000 to €0

  • Stocks and contracts +€34,809

    up €34,809 (+15.6%), from €223,202 to €258,011

  • Cash -€10,909

    down €10,909 (-3.7%), from €291,749 to €280,841

    mainly Other debts (-€192,112) and Receivables within one year (-€99,087)

Equity and liabilities
  • Other debts -€192,112

    down €192,112 (-36.4%), from €527,893 to €335,781

  • Reserves +€192,010

    up €192,010 (+241.1%), from €79,652 to €271,662

  • Current portion of long-term debt -€33,334

    down €33,334 (-83.3%), from €40,000 to €6,666

  • Trade debts +€19,358

    up €19,358 (+10.3%), from €188,553 to €207,911

Income statement
  • Taxes +€63,624

    up €63,624 (+2242.3%), from €2,837 to €66,461

  • Gross operating margin +€59,244

    up €59,244 (+14.7%), from €402,496 to €461,740

  • Staff costs -€8,838

    down €8,838 (-6.0%), from €147,491 to €138,653

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €194,931
Gross operating margin +€59,244
Staff costs +€8,838
Depreciation +€810
Other operating charges +€568
Other operating items -€209
Financial income -€2,894
Financial charges -€654
Taxes -€63,624
Result 2025 €197,010

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€63,930
Investment +€98,021
Financing -€45,000
Cash 2024 €291,749
Net result for the year +€197,010
Depreciation +€53,212
Stocks and contracts -€34,809
Receivables within one year -€99,087
Smaller working-capital items +€126
Trade debts +€19,358
Tax, wage and social debts -€7,626
Other debts -€192,112
Investment in fixed assets (net) -€8,306
Current investments +€106,327
Debts after one year -€6,666
Current portion of long-term debt -€33,334
Contributions, distributions and other -€5,000
Cash 2025 €280,841
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €880,949 €852,674 -€28,274 -3.2%
Fixed assets 21/28 €96,979 €52,073 -€44,906 -46.3%
Intangible fixed assets 21 €40,000 €0 -€40,000 -100.0%
Tangible fixed assets 22/27 €56,978 €52,073 -€4,905 -8.6%
Plant, machinery and equipment 23 €8,256 €9,954 +€1,698 +20.6%
Furniture and vehicles 24 €2,581 €2,116 -€465 -18.0%
Other tangible fixed assets 26 €46,142 €40,004 -€6,138 -13.3%
Current assets 29/58 €783,970 €800,601 +€16,631 +2.1%
Stocks and contracts in progress 3 €223,202 €258,011 +€34,809 +15.6%
Stocks 30/36 €223,202 €258,011 +€34,809 +15.6%
Amounts receivable within one year 40/41 €160,277 €259,364 +€99,087 +61.8%
Trade receivables 40 €154,680 €233,861 +€79,181 +51.2%
Other amounts receivable 41 €5,597 €25,503 +€19,906 +355.7%
Current investments 50/53 €106,327 €0 -€106,327 -100.0%
Cash at bank and in hand 54/58 €291,749 €280,841 -€10,909 -3.7%
Deferred charges and accrued income 490/1 €2,415 €2,386 -€29 -1.2%
Total equity and liabilities 10/49 €880,949 €852,674 -€28,274 -3.2%
Equity 10/15 €98,252 €290,262 +€192,010 +195.4%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €79,652 €271,662 +€192,010 +241.1%
Distributable reserves 133 €79,652 €271,662 +€192,010 +241.1%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €782,697 €562,413 -€220,284 -28.1%
Amounts payable after more than one year 17 €6,666 €0 -€6,666 -100.0%
Financial debts 170/4 €6,666 €0 -€6,666 -100.0%
Amounts payable within one year 42/48 €771,245 €557,530 -€213,715 -27.7%
Current portion of amounts payable after more than one year 42 €40,000 €6,666 -€33,334 -83.3%
Trade debts 44 €188,553 €207,911 +€19,358 +10.3%
Suppliers 440/4 €188,553 €207,911 +€19,358 +10.3%
Taxes, remuneration and social security 45 €14,799 €7,172 -€7,626 -51.5%
Taxes 450/3 €2,740 €292 -€2,448 -89.4%
Remuneration and social security 454/9 €12,059 €6,881 -€5,178 -42.9%
Other amounts payable 47/48 €527,893 €335,781 -€192,112 -36.4%
Accrued charges and deferred income 492/3 €4,786 €4,883 +€96 +2.0%
Remuneration, social security and pensions 62 €147,491 €138,653 -€8,838 -6.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €54,022 €53,212 -€810 -1.5%
Other operating charges 640/8 €968 €400 -€568 -58.7%
Non-recurring operating charges 66A €0 €209 +€209
Gross operating margin 9900 €402,496 €461,740 +€59,244 +14.7%
Operating profit (loss) 9901 €200,015 €269,266 +€69,250 +34.6%
Financial income 75/76B €8,056 €5,162 -€2,894 -35.9%
Recurring financial income 75 €8,056 €5,162 -€2,894 -35.9%
Financial charges 65/66B €10,302 €10,956 +€654 +6.3%
Recurring financial charges 65 €10,302 €10,956 +€654 +6.3%
Profit (loss) for the period before taxes 9903 €197,769 €263,471 +€65,702 +33.2%
Income taxes 67/77 €2,837 €66,461 +€63,624 +2242.3%
Profit (loss) for the period 9904 €194,931 €197,010 +€2,079 +1.1%
Profit (loss) for the period to be appropriated 9905 €194,931 €197,010 +€2,079 +1.1%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.